Thrombin-stimulated phospholipase C activity is inhibited without visible delay by a rapid increase in the cyclic GMP levels induced by sodium nitroprusside

Molecular Pharmacology

Volumn 50, Issue 2, 1996, Pages 367-379

  Azula, F J ^a   Alzola, E S ^a   Conde, M ^a   Trueba, M ^a   Macarulla, J M ^a   Marino, A ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; NITROPRUSSIDE SODIUM; PHOSPHOLIPASE C; PROTEIN KINASE; THROMBIN;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; COMPETITIVE INHIBITION; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR SPACE; HEMOSTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOSIS;

CALCIUM; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; HUMANS; METHYLENE BLUE; NITROPRUSSIDE; PHOSPHOLIPASE C; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; SEROTONIN; THROMBIN;

EID: 0029789945     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Siess, W. Molecular mechanisms of platelet activation. Physiol Rev. 69: 58-178 (1989).
2. Morgan, R. O., and A. C. Newby. Nitroprusside differentially inhibits ADP-stimulated calcium influx and mobilization in human platelets. Biochem. J. 258:447-454 (1989).
3. Nakashima, S., T. Tohmatsu, H. Hattori, Y. Okano, and Y. Nozawa. Inhibitory action of cyclic GMP on secretion, polyphosphoinositide hydrolysis and calcium mobilization in thrombin-stimulated human platelets. Biochem. Biophys. Res. Commun. 135:1099-1104 (1986).
4. Takai, Y., K. Kaibuchi, T. Matsubara, and Y. Nishizuka. Inhibitory action of guanoeine 3′,5′-monophosphate on thrombin-induced phosphatidylinositol turnover and protein phosphorylation in human platelets. Biochem. Biophys. Res. Commun. 101:61-67 (1981).
5. Andersson, T. L. G., and E. Vinge. Interactions between isoprenaline, sodium nitroprusside, and isozyme-selective phosphodiesterase inhibitors on ADP-induced aggregation and cyclic nucleotide levels in human platelets. J. Cardiovasc. Pharmacol. 18:237-242 (1991).
6. Mellion, B. T., L. J. Ignarro, C. B. Myers, E. H. Ohlstein, B. A. Ballot, A. L. Hyman, and P. J. Kadowitz. Inhibition of human platelet aggregation by S-nitrosothiols: heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation. Mol. Pharmacol. 23:653-664 (1983).
7. 2+ and on aggregation of human platelets. Eur. J. Pharmacol. 245:281-284 (1993).
8. Waldmann, R., and U. Walter. Cyclic nucleotides elevating vasodilators inhibit platelet aggregation at an early step of the activation cascade. Eur. J. Pharmacol. 159:317-320 (1989).
9. Brüne, B., and V. Ullrich. Cyclic nucleotides and intracellular-calcium homeostasis in human platelets. Eur. J. Biochem. 207:607-613 (1992).
10. Geiger, J., C. Nolte, E. Butt, S. O. Sage, and U. Walter. Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonists-evoked calcium elevation in human platelets. Proc. Natl. Acad. Sci. USA 89:1031-1035 (1992).
11. MacIntyre, D. E., M. Bushfield, and A. M. Shaw. Regulation of platelet cytosolic free calcium by cyclic nucleotides and protein kinase C. FEBS Lett. 188:383-388 (1985).
12. Sane, D. C., A. Bielawska, C. S. Greenberg, and Y. A. Hannun. Cyclic GMP analogs inhibit gamma thrombin-induced arachidonic acid release in human platelets. Biochem. Biophys. Res. Commun. 165:708-714 (1989).
13. Butt, E., C. Nolte, S. Schulz, J. Beltman, J. A. Beavo, B. Jastorff, and U. Walter. Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-para-chlorophenyl-thio-cGMP. Biochem. Pharmacol. 43:2591-2600 (1992).
14. Eigenthaler, M., H. Ullrich, J. Geiger, K. Horstrup, P. Hönig-Liedl, D. Wiebecke, and U. Walter. Defective nitrovasodilator-stimulated protein phosphorylation and calcium regulation in cGMP-dependent protein kinase-deficient human platelets of chronic myelocytic leukemia. J. Biol. Chem. 268:13526-13531 (1993).
15. Geiger, J. C. Nolte, and U. Walter. Regulation of calcium mobilization and entry in human platelels by endolhelium-derived factors. Am. J. Physiol. 267:C236-C244 (1994).
16. Eigenthaler, M., C. Nolte, M. Halbrügge, and U. Walter. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets: estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells. Eur. J. Biochem. 205:471-481 (1992).
17. Halbrügge, M., C. Friedrich, M. Eigenthaler, P. Schanzenbächer, and U. Walter. Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators. J. Biol. Chem. 265:3088-3093 (1990).
18. Waldmann, R., M. Nieberding, and U. Walter. Vasodilator-stimulated protein phosphorylation in platelets is mediated by cAMP- and cGMP-dependent protein kinases. Eur. J. Biochem. 167:441-448 (1987).
19. Halbrügge, M., and U. Walter. Purification of a vasodilator-regulated phosphoprotein from human platelets. Eur. J. Biochem. 185:41-50 (1989).
20. Reinhard, M., M. Halbrügge, U. Scheer, C. Wiegend, B. M. Jockusch, and U. Walter. The 46/50 kDa phosphoprotein VASP purified from human platelets is a novel protein associated with actin filaments and focal contacts. EMBO J. 11:2063-2070 (1992).
21. Horstrup, K., B. Jablonka, P. Hönig-Liedl, M. Just, K. Kochsiek, and U. Walter. Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition. Eur. J. Biochem. 225:21-27 (1994).
22. Maurice, D. H., and R. J. Haslam. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Mol. Pharmacol. 37:671-681 (1990).
23. 1. J. Cardiovasc. Pharmacol. 17:424-433 (1991).
24. Haslam, R. J., and M. M. L. Davidson. Roles of cyclic AMP and cyclic GMP in the inhibition of platelet function by nitroprusside and phosphodiesterase inhibitors. Circulation 66 (Suppl. II):II-291 (1982).
25. Lincoln, T. M., and T. L. Cornwell. Intracellular cyclic GMP receptor proteins. FASEB J. 7:328-338 (1993).
26. Hawkins, D. J., B. O. Meyrick, and J. J. Murray. Activation of guanylate cyclase and inhibition of platelet aggregation by endothelium-derived relaxing factor released from cultured cells. Biochim. Biophys. Acta 969:289-296 (1988).
27. Brüne, B., and V. Ullrich: 12-Hydroperoxyeicosatetranoic acid inhibits main platelet functions by activation of soluble guanylate cyclase. Mol. Pharmacol. 39:671-678 (1991).
28. 2+ impairs thrombin-induced signal transduction by acting on the agonists and/or receptor in human platelets. Am. J. Physiol. 265:C1681-C1688 (1993).
29. 2+ mobilization and not calcium influx promotes phorbol ester-stimulated thromboxane A2 synthesis in human platelets. Prostaglandins 43:383-395 (1992).
30. Holmsen, H., and C. A. Dangelmaier. Measurement of secretion of serotonin. Methods Enzymol. 169 (Part A):205-210 (1989).
31. Cobbold, P. H., and T. J. Rink. Fluorescence and bioluminescence measurement of cytoplasmic free calcium. Biochem. J. 248:313-328 (1987).
32. De Caterina, R., and R. Sicari. Cellular effects of thrombin: pharmacology of the receptor(s) in various cell types and possible development of receptor antagonists. Pharmacol. Res. 27:1-19 (1993).
33. Vu, T.-K. H., D. T. Hung, V. I. Wheaton, and S. R. Coughlin. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057-1068 (1991).
34. Wu, X.-B., B. Brune, F. V. Appen, and V. Ullrich. Efflux of cyclic GMP from activated human platelets. Mol. Pharmacol. 43:564-568 (1993).
35. Nolte, C., M. Eigenthaier, K. Horstrup, P. Hönig-Liedl, and U. Walter. Synergistic phosphorylation of the focal adhesion-associated vasodilator-stimulated phosphoprotein in intact human platelets in response to cGMP- and cAMP-elevating platelet inhibitors. Biochem. Pharmacol. 48:1569-1575 (1994).
36. Kase, H., K. Iwahashi, S. Nakanishi, Y. Matsuda, K. Yamada, M. Takahashi, C. Murakata, A. Sato, and M. Kaneko. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun. 142:436-440 (1987).
37. Butt, E., M. Eigenthaler, and H.-G. Genieser. (Rp)-8-pCPT-cGMPS, a novel cGMP-dependent protein kinase inhibitor. Eur. J. Pharmacol. 269: 265-268 (1994).
38. Dostmann, W. R. G., S. S. Taylor, H.-G. Genieser, B. Jastorff, S. O. Doskeland, and D. Ogreid. Probing of the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3′,5′-cyclic phosphorothioates. J. Biol. Chem. 265:10484-10491 (1990).
39. Sandberg, M., E. Butt, C. Nolte, L. Fischer, M. Halbrügge, J. Beltman, T. Jahnsen, H.-G. Genieser, B. Jastorff, and U. Walter. Characterization of Sp-5,6-dichioro-1-β-D-ribofuranosyl-benzirnidazole-3′,5′- monophosphorothioate (Sp-5,6-DCl-cBiMPS) as a potent and specific activator of cyclic-AMP-dependent protein kinase in cell extracts and intact cells. Biochem. J. 279:521-527 (1991).
40. Murray, K J., R. J. Eden, J. S. Dolan, D. C. Grimsditch, C. A. Stutchbury, B. Potel, A. Knowles, A. Worby, J. A. Lynham, and W. J. Coates. The effects of SK&F 95654, a novel phosphodiesterase inhibitor, on cardiovascular, respiratory and platelet function. Br. J. Pharmacol. 107:463-470 (1992).
41. Seiler, S., E. Gillespie, A. J. Arnold, C. L. Brassard, N. A. Meanwell, and J. S. Fleming. Imidazoquinoline derivates: potent inhibitors of platelet cyclic AMP phosphodiesterase which elevate cyclic AMP levels and activate protein kinase in platelets. Thromb. Res. 62:31-42 (1991).
42. Wahler, G. M., and S. J. Dollinger. Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase. Am. J. Physiol. 268:C45-C54 (1995).
43. Murthy, K. S., and G. M. Makhlouf. Interaction of cA-kinase and cG-kinase in mediating relaxation of dispersed smooth muscle cells. Am. J. Physiol. 268:C171-C180 (1995).
44. Wyatt, T. A., T. M. Lincoln, and K. B. Pryzwansky. Vimentin is transiently co-localized with and phosphorylated by cyclic GMP-dependent protein kinase in formyl-peptide stimulated neutrophils. J. Biol. Chem. 266: 21274-21280 (1991).
45. Wyatt, T. A., K. B. Pryzwansky, and T. M. Lincoln. KT-5823 activates human neutrophils and fails to inhibit cGMP-dependent protein kinase phosphorylation of vimentin. Res. Commun. Chem. Pathol. Pharmacol. 74:3-14 (1991).